Cargando…
Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus
Exosomes have been proposed as candidates for therapeutic immunization. The present study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into exosome-like vesicles (ELVs) enhances their uptake and induces the maturation of dendritic cells. Targeting of VSV-G a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115564/ https://www.ncbi.nlm.nih.gov/pubmed/18538453 http://dx.doi.org/10.1016/j.vaccine.2008.04.069 |
_version_ | 1783514124411469824 |
---|---|
author | Temchura, Vladimir V. Tenbusch, Matthias Nchinda, Godwin Nabi, Ghulam Tippler, Bettina Zelenyuk, Maryna Wildner, Oliver Überla, Klaus Kuate, Seraphin |
author_facet | Temchura, Vladimir V. Tenbusch, Matthias Nchinda, Godwin Nabi, Ghulam Tippler, Bettina Zelenyuk, Maryna Wildner, Oliver Überla, Klaus Kuate, Seraphin |
author_sort | Temchura, Vladimir V. |
collection | PubMed |
description | Exosomes have been proposed as candidates for therapeutic immunization. The present study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into exosome-like vesicles (ELVs) enhances their uptake and induces the maturation of dendritic cells. Targeting of VSV-G and ovalbumin as a model antigen to the same ELVs increased the cross-presentation of ovalbumin via an endosomal acidification mechanism. Immunization of mice with VSV-G and ovalbumin containing ELVs led to an increased IgG2a antibody response, expansion of antigen-specific CD8 T cells, strong in vivo CTL responses, and protection from challenge with ovalbumin expressing tumor cells. Thus, incorporation of VSV-G and targeting of antigens to ELVs are attractive strategies to improve exosomal vaccines. |
format | Online Article Text |
id | pubmed-7115564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71155642020-04-02 Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus Temchura, Vladimir V. Tenbusch, Matthias Nchinda, Godwin Nabi, Ghulam Tippler, Bettina Zelenyuk, Maryna Wildner, Oliver Überla, Klaus Kuate, Seraphin Vaccine Article Exosomes have been proposed as candidates for therapeutic immunization. The present study demonstrates that incorporation of the G protein of vesicular stomatitis virus (VSV-G) into exosome-like vesicles (ELVs) enhances their uptake and induces the maturation of dendritic cells. Targeting of VSV-G and ovalbumin as a model antigen to the same ELVs increased the cross-presentation of ovalbumin via an endosomal acidification mechanism. Immunization of mice with VSV-G and ovalbumin containing ELVs led to an increased IgG2a antibody response, expansion of antigen-specific CD8 T cells, strong in vivo CTL responses, and protection from challenge with ovalbumin expressing tumor cells. Thus, incorporation of VSV-G and targeting of antigens to ELVs are attractive strategies to improve exosomal vaccines. Elsevier Ltd. 2008-07-04 2008-05-16 /pmc/articles/PMC7115564/ /pubmed/18538453 http://dx.doi.org/10.1016/j.vaccine.2008.04.069 Text en Copyright © 2008 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Temchura, Vladimir V. Tenbusch, Matthias Nchinda, Godwin Nabi, Ghulam Tippler, Bettina Zelenyuk, Maryna Wildner, Oliver Überla, Klaus Kuate, Seraphin Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus |
title | Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus |
title_full | Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus |
title_fullStr | Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus |
title_full_unstemmed | Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus |
title_short | Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus |
title_sort | enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent g protein of vesicular stomatitis virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115564/ https://www.ncbi.nlm.nih.gov/pubmed/18538453 http://dx.doi.org/10.1016/j.vaccine.2008.04.069 |
work_keys_str_mv | AT temchuravladimirv enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT tenbuschmatthias enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT nchindagodwin enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT nabighulam enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT tipplerbettina enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT zelenyukmaryna enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT wildneroliver enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT uberlaklaus enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus AT kuateseraphin enhancementofimmunostimulatorypropertiesofexosomalvaccinesbyincorporationoffusioncompetentgproteinofvesicularstomatitisvirus |